Impressive OVERALL SURVIVAL Data From DELLphi-303:Will TARLATAMAB Become Standard Of Care in FIRST-LINE SMALL CELL LUNG CANCER ? Tom Newsom-Davis And Shobhit Baijal Discuss,in The BTOG 'ESMO Top 10' Webcast .